BioSpace News Archive

Business

Statement from Mylan’s Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer

Mylan’s Board of Directors shared the following statement regarding Heather Bresch’s retirement, which will be effective upon the closing of the combination of Mylan and Upjohn, a division of Pfizer.

July 29, 2019
·
10 min read
Drug Development

European Medicines Agency Adopts Positive Opinion for Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Advanced Renal Cell Carcinoma

Opinion Granted Based on Significant Overall Survival Benefit for KEYTRUDA in Combination with Axitinib Compared to Sunitinib in Phase 3 KEYNOTE-426 Trial

July 29, 2019
·
33 min read
Business

Mylan and Upjohn, a Division of Pfizer, to Combine, Creating a New Champion for Global Health Uniquely Positioned to Fulfill the World’s Need for Medicine

Combines Mylan’s sustainable, diverse and differentiated portfolio of medicines with Upjohn’s trusted, iconic brands

July 29, 2019
·
22 min read
Deals

Pfizer Inc. Reschedules Second-Quarter 2019 Earnings Conference Call to July 29, 2019 at 10:30 a.m. EDT

Pfizer’s second-quarter 2019 earnings conference call with investment analysts has been rescheduled for, July 29, 2019, at 10:30 a.m. EDT.

July 29, 2019
·
1 min read
Drug Development

Merck’s KEYTRUDA® (pembrolizumab) in Combination with Chemotherapy Met Primary Endpoint of Pathological Complete Response (pCR) in Pivotal Phase 3 KEYNOTE-522 Trial in Patients with Triple-Negative Breast Cancer (TNBC)

KEYTRUDA is the First Anti-PD-1 Therapy to Demonstrate a Statistically Significant Improvement in pCR Rates as Neoadjuvant Therapy for TNBC Regardless of PD-L1 Status

July 29, 2019
·
30 min read
Business

Laboratoire Synbionyme Urges Everyone to Take Precautions Against too Much Sun During National Ultraviolet Safety Month in July

Laboratoire Synbionyme, a Paris-based skincare company, urges everyone to use National Ultraviolet Safety Month in July as the kick-starter to protect their skin.

July 29, 2019
·
2 min read
Business

World Pharmatech’s XtraLast® Offers 16 Clinically-Tested Ingredients in its Holistic Alternative to ED Drugs

World Pharmatech developed XtraLast® to help the 12 million men in the U.S. with some form of erectile dysfunction.

July 29, 2019
·
2 min read
Deals

NEC Acquires Norwegian Bioinformatics Company, OncoImmunity AS

NEC Corporation announced the acquisition of OncoImmunity AS, a Norway-based bioinformatics company that develops proprietary machine learning software to support the fight against cancer.

July 29, 2019
·
2 min read
Deals

Magenta Medical Closes Funding Round Led by NEA in Its First-Ever Life Sciences Investment in Israel

Existing investors also participated in the round to further Magenta’s development of miniaturized pumps to treat heart failure patients

July 29, 2019
·
4 min read
Business

Neptune to Hold Conference Call to Discuss First Quarter Results Ended June 30, 2019

The first quarter results press release will be issued on August 14, 2019 before the conference call.

July 29, 2019
·
2 min read